Correlation Between Neurocrine Biosciences and WESCO

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and WESCO at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and WESCO into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and WESCO Distribution 725, you can compare the effects of market volatilities on Neurocrine Biosciences and WESCO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of WESCO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and WESCO.

Diversification Opportunities for Neurocrine Biosciences and WESCO

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Neurocrine and WESCO is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and WESCO Distribution 725 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WESCO Distribution 725 and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with WESCO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WESCO Distribution 725 has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and WESCO go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and WESCO

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 8.94 times more return on investment than WESCO. However, Neurocrine Biosciences is 8.94 times more volatile than WESCO Distribution 725. It trades about 0.32 of its potential returns per unit of risk. WESCO Distribution 725 is currently generating about -0.13 per unit of risk. If you would invest  12,659  in Neurocrine Biosciences on September 28, 2024 and sell it today you would earn a total of  1,244  from holding Neurocrine Biosciences or generate 9.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Neurocrine Biosciences  vs.  WESCO Distribution 725

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
WESCO Distribution 725 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days WESCO Distribution 725 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, WESCO is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Neurocrine Biosciences and WESCO Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and WESCO

The main advantage of trading using opposite Neurocrine Biosciences and WESCO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, WESCO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WESCO will offset losses from the drop in WESCO's long position.
The idea behind Neurocrine Biosciences and WESCO Distribution 725 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules